Literature DB >> 6112609

Iron and the sex difference in heart disease risk.

J L Sullivan.   

Abstract

Premenopausal women in affluent societies are protected from heart diseases which kill large numbers of men. The basis for this sex difference and the loss of protection with menopause is unknown. The hypothesis offered is that the greater incidence of heart diseases in men and postmenopausal women compared with the incidence in premenopausal women is due to higher levels of stored iron in these two groups. The hypothesis is supported by observations of (1) myocardial failure in iron strong disease, (2) accumulation of stored iron with age in men, and (3) accumulation of stored iron after menopause to levels found in men. In addition, the heart diseases of affluence are rare among impoverished peoples who are often iron deficient. The depletion of iron stores by regular phlebotomy could be the experimental system for testing this hypothesis, and a preventive therapy if the hypothesis is confirmed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6112609     DOI: 10.1016/s0140-6736(81)92463-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  149 in total

1.  The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease.

Authors:  S Campbell; D K George; S D Robb; R Spooner; T A McDonagh; H J Dargie; P R Mills
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

2.  Heterozygosity for the haemochromatosis mutation HFE C282Y is not a risk factor for angina.

Authors:  G P Feeney; P A L Ashfield-Watt; M L Burr; F D J Dunstan; I F W McDowell; M Worwood
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

3.  Possible association of a reduction in cardiovascular events with blood donation.

Authors:  D G Meyers; D Strickland; P A Maloley; J K Seburg; J E Wilson; B F McManus
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

Review 4.  Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver.

Authors:  Elmar Aigner; Günter Weiss; Christian Datz
Journal:  World J Hepatol       Date:  2015-02-27

Review 5.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

6.  Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.

Authors:  H Zheng; X Huang; Q Zhang; S D Katz
Journal:  Kidney Int       Date:  2006-02       Impact factor: 10.612

Review 7.  The big idea: the coxib crisis iron, aspirin and heart disease risk revisited.

Authors:  Jerome L Sullivan
Journal:  J R Soc Med       Date:  2007-07       Impact factor: 5.344

8.  Excessive body iron stores are not associated with risk of coronary heart disease in women.

Authors:  Qi Sun; Jing Ma; Nader Rifai; Oscar H Franco; Kathryn M Rexrode; Frank B Hu
Journal:  J Nutr       Date:  2008-12       Impact factor: 4.798

9.  Eicosapentaenoic Acid, heart disease and iron.

Authors:  J L Sullivan
Journal:  West J Med       Date:  1985-04

10.  Serum ferritin-a novel risk factor in acute myocardial infarction.

Authors:  M P Holay; A A Choudhary; S D Suryawanshi
Journal:  Indian Heart J       Date:  2012-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.